Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-136829
Filing Date
2024-12-16
Accepted
2024-12-16 19:32:19
Documents
1
Period of Report
2024-12-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 15275
  Complete submission text file 0000950170-24-136829.txt   21605
Mailing Address ATHYRIUM CAPITAL MANAGEMENT, LP 505 FIFTH AVENUE, FL 18 NEW YORK NY 10017
Business Address
Ferrell Jeffrey (Reporting) CIK: 0001394967 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 241553261

Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Issuer) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities Associates III GP LLC (Reporting) CIK: 0001815211 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 241553257

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Funds GP Holdings LLC (Reporting) CIK: 0001815225 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 241553259

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities Associates Co-Invest LLC (Reporting) CIK: 0001815259 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 241553260

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities III Co-Invest 1 LP (Reporting) CIK: 0001815260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 241553265

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities 2020 LP (Reporting) CIK: 0001815261 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 241553262

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities Associates III LP (Reporting) CIK: 0001815262 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 241553258

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities III Acquisition 2 LP (Reporting) CIK: 0001815268 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 241553263

Mailing Address 505 FIFTH AVENUE, 18TH FLOOR NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, 18TH FLOOR NEW YORK NY 10017 646-434-1636
Athyrium Opportunities III Acquisition LP (Reporting) CIK: 0001835266 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 241553264